Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 172,106 |
|
|||||
| News | - | ||||||
| Day High | 2.45 | Low High |
|||||
| Day Low | 2.17 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Lexaria Bioscience Corporation | LEXX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.16 | 7.31% | 2.35 | 18:33:04 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.17 | 2.17 | 2.45 | 2.35 | 2.19 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 514 | 172,106 | US$ 2.27 | US$ 390,353 | - | 0.6488 - 6.85 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:21:32 | 1 | US$ 2.35 | USD |
Lexaria Bioscience Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 0 | 10.28M | - | 226k | -6.67M | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Lexaria Bioscience News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/06/2024 | 05:00 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 3/01/2024 | 13:28 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/16/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/16/2024 | 14:47 | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities |
| 2/14/2024 | 13:20 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
| 2/14/2024 | 11:00 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 1/30/2024 | 12:51 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/24/2024 | 13:12 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/24/2024 | 12:33 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration.. |
| 1/18/2024 | 13:38 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
| 1/12/2024 | 16:11 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 1/11/2024 | 07:30 | GlobeNewswire Inc. | Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LEXX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.26 | 2.45 | 2.15 | 2.22 | 54,223 | 0.09 | 3.98% |
| 1 Month | 3.82 | 3.82 | 1.85 | 2.59 | 192,263 | -1.47 | -38.48% |
| 3 Months | 1.61 | 6.85 | 1.50 | 3.55 | 522,971 | 0.74 | 45.96% |
| 6 Months | 1.12 | 6.85 | 1.08 | 3.11 | 308,315 | 1.23 | 109.82% |
| 1 Year | 2.18 | 6.85 | 0.6488 | 2.42 | 221,395 | 0.17 | 7.80% |
| 3 Years | 5.31 | 12.50 | 0.6488 | 5.24 | 363,892 | -2.96 | -55.74% |
| 5 Years | 4.05 | 12.50 | 0.6488 | 5.29 | 350,484 | -1.70 | -41.98% |
Lexaria Bioscience Description
| Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio. |
